Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

被引:83
|
作者
Shen, Feng [1 ]
Zheng, Rui-Dan [2 ]
Mi, Yu-Qiang [3 ]
Wang, Xiao-Ying [4 ]
Pan, Qin [1 ]
Chen, Guang-Yu [1 ]
Cao, Hai-Xia [1 ]
Chen, Ming-Li [5 ]
Xu, Liang [3 ]
Chen, Jian-Neng [2 ]
Cao, Yi [1 ]
Zhang, Rui-Nan [1 ]
Xu, Lei-Ming [1 ]
Fan, Jian-Gao [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Gastroenterol, Xinhua Hosp, Sch Med, Shanghai 200092, Peoples R China
[2] Xiamen Univ, Affiliated Dongnan Hosp, Res & Therapy Ctr Liver Dis, Zhangzhou 363000, Fujian Province, Peoples R China
[3] Tianjin Hosp Infect Dis, Tianjin Res Inst Liver Dis, Tianjin 300192, Peoples R China
[4] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Pathol, Sch Med, Shanghai 200092, Peoples R China
[5] Shanghai Jiao Tong Univ, Dept UItrasound, Xinhua Hosp, Sch Med, Shanghai 200092, Peoples R China
关键词
Fatty liver; Nonalcoholic; Controlled attenuation parameter; Transient elastography; Chronic hepatitis B; FATTY LIVER-DISEASE; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; FIBROSIS; CAP; CHALLENGES; VALIDATION; DIAGNOSIS; TOOL;
D O I
10.3748/wjg.v20.i16.4702
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the performance of a novel non-inva-sive controlled attenuation parameter (CAP) to assess liver steatosis. METHODS: This was a multi-center prospective cohort study. Consecutive patients (aged >= 18 years) who had undergone percutaneous liver biopsy and CAP measurement were recruited from three Chinese liver centers. Steatosis was categorized as S0: < 5%; S1: 5%-33%; S2: 34%-66%; or S3: >= 67%, according to the nonalcoholic fatty liver disease (NAFLD) activity score. The FibroScan((R)) 502 equipped with the M probe (Echosens, Paris, France) was used to capture both CAP and liver stiffness measurement values simultaneously. Receiver operating characteristic curves were plotted, and the areas under the curves were calculated to determine the diagnostic efficacy. The accuracy of the CAP values at the optimal thresholds was defined by maximizing the sum of sensitivity and specificity (maximum Youden index). RESULTS: A total of 152 patients were recruited, including 52 (34.2%) patients with NAFLD and 100 (65.8%) with chronic hepatitis B (CHB) virus infection. After adjustment, the steatosis grade (OR = 37.12; 95% CI: 21.63-52.60, P < 0.001) and body mass index (BMI, OR = 6.20; 95% CI: 2.92-9.48, P < 0.001) were found independently associated with CAP by multivariate linear regression analysis. CAP was not influenced by inflammation, fibrosis or aetiology. The median CAP values and interquartile ranges among patients with S0, S1, S2 and S3 steatosis were 211 (181-240) dB/m, 270 (253-305) dB/m, 330 (302-360) dB/m, and 346 (313-363) dB/m, respectively. The cut-offs for the CAP values in all patients with steatosis >= 5%, >= 34% and >= 67% were 253 dB/m, 285 dB/m and 310 dB/m, respectively. The areas under the curves were 0.92, 0.92 and 0.88 for steatosis >= 5%, >= 34% and >= 67%, respectively. No significant differences were found in the CAP values between the NAFLD group and the CHB group in each steatosis grade.
引用
收藏
页码:4702 / 4711
页数:10
相关论文
共 50 条
  • [21] Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis
    Bader, Razan M.
    Jonas, Maureen M.
    Mitchell, Paul D.
    Wiggins, Shanna
    Lee, Christine K.
    JOURNAL OF CYSTIC FIBROSIS, 2019, 18 (02) : 280 - 285
  • [22] Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
    Broering, Dieter
    Shawkat, Mohamed
    Albenmousa, Ali
    Abaalkhail, Faisal
    Alabbad, Saleh
    Al-Hamoudi, Waleed
    Alghamdi, Saad
    Alqahthani, Saleh
    Jaafari, Ahmad
    Troisi, Roberto
    Bzeizi, Khalid
    PLOS ONE, 2021, 16 (05):
  • [23] Diagnostic Accuracy of FibroScan Controlled Attenuation Parameter (CAP) as a Non-Invasive Test for Steatosis in Liver Transplant Recipients
    Kothadia, Jiten P.
    Cheng, Tony M.
    Redfield, Jordan
    Snell, Peter D.
    Mohan, Rahul
    Faust, Thomas W.
    Nair, Satheesh P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S897 - S898
  • [24] NON-INVASIVE SURROGATE MARKERS OF HEPATIC STEATOSIS IN PATIENTS WITH NAFLD
    Salazar, Jesus Enrique Romero
    Socorro, Ana Lucia Romero
    Phan, Quynh-An
    Gutierrez, Geovanny Manuel
    Nguyen, Natalie
    Sanchez, Javier
    Egwim, Chukwuma
    Ankoma-Sey, Victor
    HEPATOLOGY, 2022, 76 : S870 - S871
  • [25] VALIDATION OF CONTROLLED ATTENUATION PARAMETER (CAP) AS A NON-INVASIVE MARKER OF STEATOSIS IN 228 PATIENTS WITH CHRONIC LIVER DISEASE FROM VARIOUS CAUSES
    Beaugrand, M.
    de Ledinghen, V.
    Douvin, C.
    Marcellin, P.
    Poupons, R.
    Fournier, C.
    Sandrin, L.
    Miette, V.
    Sasso, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S35 - S36
  • [26] NON-INVASIVE MEASUREMENT OF LIVER STEATOSIS BY CONTROLLED ATTENUATION PARAMETER (CAP) USING Fibroscan® IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Enooku, K.
    Tateishi, R.
    Fujiwara, N.
    Mikami, S.
    Minami, T.
    Sato, M.
    Uchino, K.
    Kondo, Y.
    Yoshida, H.
    Ikeda, H.
    Koike, K.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S536 - S537
  • [27] Controlled attenuation parameter for the detection of hepatic steatosis in patients with chronic hepatitis B
    Chen, Jing
    Wu, Dongbo
    Wang, Menglan
    Chen, Enqiang
    Bai, Lang
    Liu, Cong
    Liao, Juan
    Tang, Hong
    INFECTIOUS DISEASES, 2016, 48 (09) : 670 - 675
  • [28] ACCURACY OF CONTROLLED ATTENUATION PARAMETER (CAP) TO PREDICT HEPATIC STEATOSIS IN OBESE PATIENTS
    Owen, Samuel
    King, Christopher
    Cho, Ryan
    Juakiem, Wassem
    Sarkar, Sonali
    Aden, James
    Morales-Cardona, Amilcar L.
    Paredes, Angelo H.
    HEPATOLOGY, 2019, 70 : 1084A - 1085A
  • [29] CONTROLLED ATTENUATION PARAMETER (CAP) FOR NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS IN THE GENERAL POPULATION: CORRELATION WITH ULTRASOUND (US) AND FATTY LIVER INDEX (FLI)
    Carvalhana, S.
    Leitao, J.
    Alves, A. C.
    Bourbon, M.
    Cortez-Pinto, H.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S533 - S534
  • [30] Comparison Between Attenuation Measurement and the Controlled Attenuation Parameter for the Assessment of Hepatic Steatosis Based on MRI Images
    Gotoh, Tatsuya
    Kumada, Takashi
    Ogawa, Sadanobu
    Niwa, Fumihiko
    Toyoda, Hidenori
    Hirooka, Masashi
    Koizumi, Yohei
    Hiasa, Yoichi
    Akita, Tomoyuki
    Tanaka, Junko
    Shimizu, Masahito
    LIVER INTERNATIONAL, 2025, 45 (01)